Shanghai INT Medical profit rises 22.68% to RMB 125.67 million in H1 FY26; revenue climbs 29.28% to RMB 596.06 million

• Shanghai Int Medical Instruments posted revenue of RMB 596.06 million for the six months ended June 30, up 29.28%.
• Profit for the period climbed 22.68% to RMB 125.67 million, while basic earnings per share fell 5.26% to RMB 0.54.
• Gross profit rose 34.63% to RMB 364.38 million as gross margin widened 2.43 percentage points to 61.13%.
• Interventional medical devices revenue increased 36.07% to RMB 533.88 million, while agent business revenue dropped 41.59% to RMB 18.93 million.
• Board resolved not to declare an interim dividend; the company continued pursuing the Valgen Holding stake acquisition and progressed a proposed A-share issuance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260824-12296943), on August 24, 2026, and is solely responsible for the information contained therein.